San Diego, CA—CV Sciences has announced an ongoing partnership with Alkemist Labs in a press release. The two will collaborate with the National Institute of Standards and Technology (NIST) on efforts to help cannabis testing labs demonstrate and improve measurement capabilities and comparability.

The tools developed by the NIST cannabis program will support measurements establishing legal, commerce, and safety claims through the development of fit-for-purpose analytical methodologies, production of Reference Materials, and implementation ofNIST’s Cannabis Quality Assurance Program, CannaQAP.

CV Sciences will prepare and provide hemp oil samples, which NIST will distribute to laboratories that participate in CannaQAP. Alkemist Labs will provide initial measurements of cannabinoid levels in those samples.

CannaQAP will improve the accuracy and capability of cannabis product testing, and will benefit forensic laboratories that are developing analytical methods to distinguish hemp from marijuana; quality control laboratories testing cannabis products for strength and composition; regulatory laboratories testing for product compliance; and researchers conducting clinical trials on the safety and benefits of cannabis products.

Related: Alkemist Labs ISO Accredited for Cannabis Building Trust: Third-Party Lab Testing and Certifications Sen. Rand Paul Reintroduces HEMP Act

“As one of the first accredited cannabis testing labs in California, Alkemist Labs has a long history as a strong advocate for rigorous laboratory standards for cannabis products,” said Alkemist Labs CEO Elan Sudberg in the press release. “We’re very pleased to be partnering with CV Sciences and NIST on this important effort to ensure that labs have the fit-for-purpose test methods they need to support high quality standards of cannabis products.”

“As the most trusted hemp-derived CBD company, CV Sciences was honored to be invited to partner with Alkemist Labs to assist NIST in its efforts to improve cannabis testing throughout the industry,” adde Dr. Douglas Mackay, N.D., Senior Vice President of Scientific and Regulatory Affairs for CV Sciences. “We are dedicated to moving the CBD industry forward through science and advancing NIST’s CannaQAP program will play a pivotal role in helping the industry improve the scientific rigor and reproducibility between Cannabis testing labs.”